The N-terminal fragment of GRP94 is sufficient for peptide presentation via professional antigen-presenting cells

42Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The chaperone glucose-regulated protein 94 (GRP94) has long been used to augment peptide presentation to T cells. This chaperone binds antigenic peptides, binds to receptors on professional antigen-presenting cells (APCs), activates these cells and after internalization, transfers the peptides to MHC class I for activation of T cells. Here we show that all these activities reside within amino acids 1-355 of GRP94. This small fragment is sufficient to bind peptides, to bind and be taken up by the receptors CD91 and scavenger receptor type A on either dendritic cells or macrophages. The minimal construct can augment peptide presentation in culture and induce antigen-specific CTL in naive mice only because it loads APCs with the relevant peptide. Thus, the sequence 1-355 is the immunologically sufficient module of GRP94 and we propose that this 'mini-chaperone' can be used in immunotherapy of tumors and vaccine development. © 2006 Oxford University Press.

Cite

CITATION STYLE

APA

Biswas, C., Sriram, U., Ciric, B., Ostrovsky, O., Gallucci, S., & Argon, Y. (2006). The N-terminal fragment of GRP94 is sufficient for peptide presentation via professional antigen-presenting cells. International Immunology, 18(7), 1147–1157. https://doi.org/10.1093/intimm/dxl049

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free